Human immunodeficiency virus infection and child sexual abuse

South African Medical Journal

Volumn 94, Issue 9, 2004, Pages 782-785

  Schaaf, Hendrik Simon ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ARTICLE; CHILD; CHILD SEXUAL ABUSE; DISEASE TRANSMISSION; DRUG DOSE REGIMEN; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; PATIENT COUNSELING; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; SOUTH AFRICA;

ANTI-HIV AGENTS; CHILD; CHILD ABUSE, SEXUAL; FEMALE; HIV INFECTIONS; HUMANS; INFORMED CONSENT; MALE; MASS SCREENING; RISK FACTORS; TRUTH DISCLOSURE;

EID: 4644294691     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Gutman LT, Herman-Giddens ME, McKinney RE. Pediatric acquired immunodeficiency syndrome: Barriers to recognizing the role of child sexual abuse. Am J Dis Child 1993;147: 775-780.
2. Mok JYQ. When is HIV an issue after child sexual abuse? Arch Dis Child 1996; 75: 85-87.
3. Jewkes R, Levin J, Mbananga N, Bradshaw D. Rape of girls in South Africa. Lancet 2002; 359: 319-320.
4. Lema VM. Sexual abuse of minors: emerging medical and social problem in Malawi. East Afr Med J 1997; 743-746.
5. Van As AB, Withers M, du Toit N, Millar AJW, Rode H. Child rape - patterns of injury, management and outcome. S Afr Med J 2001; 91: 1035-1038.
6. Lindegren ML, Hanson IC, Hammett TA, Beil J, Fleming PL, Ward JW. Sexual abuse of children: intersection with the HIV epidemic. Pediatrics 1998; 102: E46.
7. Menick DM, Ngoh F. Seroprevalence of HIV infection in sexually abused children in Cameroon. Med Trop (Mars) 2003; 63: 155-158.
8. Atabaki S, Paradise JE. The medical evaluation of the sexually abused child: lessons from a decade of research. Pediatrics 1999; 104: 178-186.
9. Machuga R, Jorgenson LB, Theilade P, Nielsen C. Molecular investigation of transmission of human immunodeficiency virus type 1 in a criminal case. Clin Diagn Lab Immunol 2001; 8: 884-890.
10. Orth H, Engelbrecht S, Cotton MF, et al. HIV transmission between two siblings in Africa. AIDS 2000; 14: 896-897.
11. Merchant RC, Keshavarz R. Humanimmunodeficiency virus postexposure prophylaxis for adolescents and children. Pediatrics 2001;108: e38.
12. Centers for Disease Control and Prevention. Case-control study of HIV seroconversion in HCW's after percutaneous exposure to HIV-infected blood-France, United Kingdom, and United States, January 1988-August 1994. Morb Mortal Wkly Rep 1995; 44: 929-933.
13. Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 1997; 337: 1485-1490.
14. Weinberg GA. Postxeposure prophylaxis against human immunodeficiency virus infection after sexual assault. Pediatr Infect Dis J 2002; 21: 959-96
15. United Kingdom Health Departments. HIV Post-Exposure Prophylaxis: Guidance from the UK Chief Medical Officers' Expert Advisory Group on AIDS, London: Department of Health, 2000.
16. American Academy of Pediatrics. Human immunodeficiency virus infection. In: Pickering Lk, ed. Red Book 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, III: American Academy of Pediatrics, 2003: 360-382.
17. Hiemstra R, Rabie H, Schaaf HS, et al. Unexplained HIV-1 infection in children: documenting cases and assessing for possible risk factors. S Afr Med J 2004; 94: 188-193.
18. Babl FE, Cooper FR, Kastner B, Kharasch S, Prophylaxis against possible human immunodeficiency virus exposure after nonoccupational needlestick injuries or sexual assaults in children and adolescents. Arch Pediatr Adolesc Med 2001; 155: 680-682.
19. Gerberding JL, Katz MH. Post-exposure prophylaxis for HIV. Adv Exp Med Biol 1999; 458: 213-222.
20. Jewkes R, Martin L. The virgin cleansing myth: cases of child rape are not exotic. Lancet 2002; 359: 711
21. Bowley DMG, Pitcher GJ. Motivation behind infant rape in South Africa. Lancet 2002; 359: 1352.
22. Meel BL. The myth of child rape as a cure for HIV/AIDS in Transkei: a case report. Med Sci Law 2003; 43: 85-88.
23. Wiener LS, Battles HB,Heilman N, Sigelman CK, Pizzo PA. Factors associated with disclosure of diagnosis to children with HIV/AIDS. Pedritric AIDS and HIV Infection 1996; 7: 310-324.
24. Lester P, Chesney M, Cooke M, et al. Journal of Acquired Immunodeficiency Syndromes 2002; 31: 309-317.
25. Gerson AC, Joyner M, Fosarelli P, et al. Disclosure of HIV diagnosis to children when, where, why, and how. Journal of Pediatric Health Care 2001; 15: 161-167.
26. American Academy of Pediatrics, Committee on Pediatric AIDS. Disclosure of illness status to children and adolescents with HIV Infection. Pediatrics 1999; 103: 164-166.
27. Davis JK, Shah K. Bioethical aspect of HIV infection in children. Clin Pediatr 1997; 36: 573-579.
28. Schonfield DJ. Informing children of their human immunodeficiency virus infection. Arch Pediatr Adolesc Med 1997; 151: 976-977.
29. Sherman BF, Bonanno GA, Wiener LS, Battles HB. When children tell their friends they have AIDS: possible consequences for psychological well-being and disease progression. Psychosom Med 2000; 62: 238-247.
30. Parillo KM, Freeman RC, Collier K, Young P. Association between early sexual abuse and adult HIV-risky sexual behaviors among community-recruited women. Child Abuse Negl 2001; 25: 335-346.
31. Dilorio C, Hartwell T, Hansen N; NIMH Multisite HIV Prevention Trial Group. Childhood sexual abuse and risk behaviors among men at high risk for HIV infection. Ann J Public Health 2002; 92: 214-219.
32. Freeman RC, Parillo KM, Collier K, Rusek RW. Child and adolescent sexual abuse history in a sample of 1 490 women sexual partners of injection drug-using men. Women Health 2001; 34: 31-49.
33. Greenberg JB, Childhood sexual abuse and sexually transmitted diseases in adults: a review of and implications for STD/HIV programmes. Int J STD AIDS 2001; 12: 777-783.